Peter Maccallum Cancer Centre, Australia
Clinical trials sponsored by Peter Maccallum Cancer Centre, Australia, explained in plain language.
-
New scan may spare men unnecessary prostate biopsies
Diagnosis OngoingThis study tests whether adding a PSMA PET scan helps doctors better diagnose significant prostate cancer in men whose MRI results are unclear or negative. About 660 men with no prior prostate cancer or biopsy will be randomly assigned to receive either standard care or an additi…
Phase: PHASE3 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated Apr 29, 2026 15:04 UTC
-
New total body PET scanner could slash radiation and scan time
Knowledge-focused OngoingThis study tests a new total body PET scanner that may allow lower radiation doses and faster scans without losing image quality. Twenty-five adults with cancer will get both a standard PET scan and a scan on the new machine, using the same radioactive tracer. The goal is to see …
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC
-
New registry to track PSMA therapy results in advanced prostate cancer
Knowledge-focused OngoingThis study is a registry that collects information on 500 men with metastatic castration-resistant prostate cancer who are treated with PSMA theranostics. The main goal is to see how many men have a significant drop in PSA levels after treatment. Researchers will also track side …
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC